Form 8-K - Current report:
SEC Accession No. 0001062822-25-000005
Filing Date
2025-01-07
Accepted
2025-01-07 16:08:33
Documents
13
Period of Report
2025-01-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20250103.htm   iXBRL 8-K 22666
  Complete submission text file 0001062822-25-000005.txt   145468

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20250103.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20250103_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20250103_pre.xml EX-101.PRE 12512
15 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20250103_htm.xml XML 2738
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 25514954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)